Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Comparison of Safety Reports to the FDA from a Pilot Introduction of Peginesatide, a Third Generation Erythropoiesis Stimulating Agent Versus Those from the Usual Care Setting: Manufacturers of Biosimilars and the FDA Should Consider Pilot Introductions of These Agents

Charles L. Bennett, MD PhD, Sony Jacob, MD, Peter Georgantopoulos, MPH, MA, Judy Nichols, MSN, ACNP, Iain C Macdougall, MD

Blood (2014) 124 (21): 3516.

https://doi.org/10.1182/blood.V124.21.3516.3516

Published: 2014

Journal Articles

Rituximab-Associated Progressive Multifocal Leukoencephalopathy (PML) in HIV-Negative Patients: An Updated Report of 231 Confirmed Cases from the Southern Network on Adverse Reactions (SONAR)/Washington University Collaboration (2000-2012)

Craig S Boddy, MD, Charles L Bennett, MD PhD MPP, LeAnn B Norris, PharmD, Peter Georgantopoulos, MPH, MA, Suhong Luo, MPH, Kenneth R Carson, MD

Blood (2014) 124 (21): 4456.

https://doi.org/10.1182/blood.V124.21.4456.4456

Published: 2014

Journal Articles

Forewarned Is Forearmed- Comparison of Southern Network on Adverse Reactions (SONAR) Versus an FDA-Mandated Prospective Observational Registry Assessment of Gemtuzumab Ozogamycin-Associated Sinusoidal Obstructive Syndrome

Jametta Magwood, BA, Peter Georgantopoulos, MPH, MA, LeAnn B Norris, PharmD, Charles L. Bennett, MD PhD

Blood (2014) 124 (21): 5970.

https://doi.org/10.1182/blood.V124.21.5970.5970

Published: 2014

Journal Articles

Fatal and Serious Anaphylaxis Following Peginesatide Administration

Charles L. Bennett, MD, PhD, MPP, Sony Jacob, MD, Iain C Macdougall, MD, Tom Moore, Peter Georgantopoulos, MPH, MA, Judy Nichols, Paul Yarnold, PhD, Oliver Sartor, MD, Dennis W. Raisch, PhD, MS, RPh, Ashraf Mikhail, MD, LeAnn Norris, PharmD, Samuel Kessler, BA, Jametta Magwood, BA, David Goldsmith, MB, ChB

Blood (2013) 122 (21): 5612.

https://doi.org/10.1182/blood.V122.21.5612.5612

Published: 2013

Journal Articles

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Alyssa Trenery, Samuel Kessler, BA, Van Slooten Eleasa, BS, Akida Lebby, Charles L. Bennett, MD, PhD, MPP, Paul Yarnold, PhD, Paul Ray, DO, MA, Dennis W. Raisch, PhD, MS, RPh, Gowtham Rao, MD, PhD, Peter Georgantopoulos, MPH, MA, LeAnne Norris, PharmD, Simone Boyle, BA, Ashlyn Byrne, Matthew Bialkowski, Oliver Sartor, MD

Blood (2013) 122 (21): 2938.

https://doi.org/10.1182/blood.V122.21.2938.2938

Published: 2013

NARROW

Comparison of Safety Reports to the FDA from a Pilot Introduction of Peginesatide, a Third Generation Erythropoiesis Stimulating Agent Versus Those from the Usual Care Setting: Manufacturers of Biosimilars and the FDA Should Consider Pilot Introductions of These Agents

Rituximab-Associated Progressive Multifocal Leukoencephalopathy (PML) in HIV-Negative Patients: An Updated Report of 231 Confirmed Cases from the Southern Network on Adverse Reactions (SONAR)/Washington University Collaboration (2000-2012)

Forewarned Is Forearmed- Comparison of Southern Network on Adverse Reactions (SONAR) Versus an FDA-Mandated Prospective Observational Registry Assessment of Gemtuzumab Ozogamycin-Associated Sinusoidal Obstructive Syndrome

Fatal and Serious Anaphylaxis Following Peginesatide Administration

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Email alerts

ASH Publications

American Society of Hematology

Comparison of Safety Reports to the FDA from a Pilot Introduction of Peginesatide, a Third Generation Erythropoiesis Stimulating Agent Versus Those from the Usual Care Setting: Manufacturers of Biosimilars and the FDA Should Consider Pilot Introductions of These Agents

Rituximab-Associated Progressive Multifocal Leukoencephalopathy (PML) in HIV-Negative Patients: An Updated Report of 231 Confirmed Cases from the Southern Network on Adverse Reactions (SONAR)/Washington University Collaboration (2000-2012)

Forewarned Is Forearmed- Comparison of Southern Network on Adverse Reactions (SONAR) Versus an FDA-Mandated Prospective Observational Registry Assessment of Gemtuzumab Ozogamycin-Associated Sinusoidal Obstructive Syndrome

Fatal and Serious Anaphylaxis Following Peginesatide Administration

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only